000
| 01405nam 2200361zi 4500 |
---|
001 | 9.870481 |
---|
003 | CaOODSP |
---|
005 | 20240823083414 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 190322t20192019onc o f000 0 eng d |
---|
020 | |a9780660302379 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH164-273/2019E-PDF |
---|
245 | 00|aGuidance document : |bregulatory requirements for drug identification numbers (DINs). |
---|
250 | |a[2019/05/03 edition]. |
---|
264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019. |
---|
264 | 4|c©2019 |
---|
300 | |a1 online resource (27 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Ligne directrice : exigences réglementaires associées à une identification numérique attribuée à une drogue (DIN). |
---|
500 | |aCover title. |
---|
500 | |a"Date adopted: 2019/05/03. Effective date: 2019/05/03." |
---|
500 | |a"Publication date: May 2019." |
---|
500 | |a"Pub.: 180925." |
---|
692 | 07|2gccst|aDrugs |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
775 | 08|tLigne directrice : |w(CaOODSP)9.870482 |
---|
794 | |tGuidance document : |b[2019/06/19 edition]|w(CaOODSP)9.874552 |
---|
856 | 40|qPDF|s304 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-273-2019-eng.pdf |
---|